EastWest Adds Oliver to Its Self-Storage Location Portfolio
- Wall Street ends down as markets whipsaw ahead of Fed meeting
- Microsoft (MSFT) Stock Falls 4% Despite Q2 Beat
- Equities Selloff Isn't Over Yet, Stay Defensive and Prepare for S&P 500 Below 4,000 - Morgan Stanley's Wilson
- Texas Instruments (TXN) Shares Up 2% on Q4 Beat and Raise
- Euro falls to one-month low as Ukraine tensions simmer
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
PENTICTON, BC / ACCESSWIRE / September 24, 2021 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), reports that its self-storage focused subsidiary, 1290185 B.C. LTD, ("185"), has leased land in the heart of wine country Oliver, BC to open the next location in its self-storage portfolio.
The Oliver location will be developed as an automated self-storage facility and is scheduled to be open in the first quarter of 2022. The initial site size will be two acres with an option to expand up to four acres. Situated on the route between Osoyoos to the south and Penticton to the north, the location will cater to both residents of the area and to the significant seasonal recreational population of the region.
Rodney Gelineau, President and CEO of EastWest commented, "Oliver is an important strategic milestone for our self-storage offering. Situated in wine country, with an active recreational and seasonal population this location will be a catalyst for future self-storage locations."
EastWest will provide further details as the Oliver facility is completed, anticipated to be Q1 2022.
About EastWest Bioscience Group
EastWest Bioscience is a vertically integrated wellness company with a multitude of business units and assets that allow for seed-to-sale supply chain management. We source our raw material, process, manufacture, test, brand, market, and distribute our products to our customers in Canada, the United States, and beyond. The Company owns and operates retail and manufacturing subsidiaries.
The Company's retail subsidiary is the award winning, Canadian, natural health retail franchise - the Sangster's Health Centre's - with over 40 years of legacy in the health and wellness industry. Sangster's goal is to provide natural choices through quality products and educated advice for a healthy lifestyle. Sangster's Health Centres occupies a unique position in the industry, the stores provide vast knowledge and safe natural remedies for the prevention and treatment of disease and ailments. Sangster's introduction and development of over 202 exclusively labeled products (vitamins, mineral, herbs, proteins, natural body care and organic foods) catapulted Sangster's name and product into a large number of Canadian households. From a solid base in Saskatchewan, Sangster's has become a national brand name with franchise stores located across Canada.
Orchard Vale Naturals is the Company's manufacturing arm that is certified with a Health Canada Site License and has GMP Certified NHP Manufacturing capabilities. Orchard Vale Naturals specialize in custom blends and production runs of all sizes, small to large, for top-quality products with quick turnaround times. Orchard Vale Naturals operate out of the 34,000 sq Health Canada licensed facility in Penticton, British Columbia that is owned by EastWest Bioscience and is the Head Office for all its Canadian operations.
The Company's self-storage subsidiary 1290185 B.C. LTD ("185") is building a network of automated self-storage sites in British Columbia. The subsidiary's business model is designed to be low capex with highly scalable logistics. It is focused on secondary markets, consumer automation and innovative land partnerships, allowing it to move into new regions quickly, at scale and with minimal risk. EastWest hopes to build the forthcoming brand of 185 into a household name across Canada.
ON BEHALF OF THE BOARD OF DIRECTORS OF
EASTWEST BIOSCIENCE INC.
Co-Founder, Chief Executive Officer and Director
For Further Information:
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the matters disclosed herein. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE: EastWest Bioscience Inc.
View source version on accesswire.com:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Falcon Welcomes Media And Publishing Veteran - Michelle Suzuki To Its Board Of Directors
- Jiangsu launched 5 tourist routes to explore winter in Charm of Jiangsu
- Core One Labs’ Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences
Create E-mail Alert Related CategoriesAccesswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!